Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 3/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetraethylene Glycol SCHEMBL619243 | 1.00 | TSHR (0.52) | TSHRALDH1A1MEN1KMT2AFGFR4 | |
| Triethylene Glycol SCHEMBL617657 | 1.00 | TSHR (0.52) | TSHRALDH1A1MEN1KMT2AFGFR4 | |
| Triethylene Glycol SCHEMBL3199640 | 1.00 | TSHR (0.52) | TSHRALDH1A1MEN1KMT2AFGFR4 | |
| Pentaethylene Glycol SCHEMBL617370 | 1.00 | TSHR (0.52) | TSHRALDH1A1MEN1KMT2AFGFR4 | |
| Di(Hydroxyethyl)Ether SCHEMBL28902597 | 0.98 | TSHR (0.55) | TSHRALDH1A1MEN1KMT2AFGFR4 | |
| Di(Hydroxyethyl)Ether SCHEMBL28546498 | 0.98 | TSHR (0.55) | TSHRALDH1A1MEN1KMT2AFGFR4 | |
| Acrylamide SCHEMBL21777535 | 0.90 | TSHR (0.42) | TSHRALDH1A1MEN1KMT2AFGFR4 | |
| Triethylene Glycol SCHEMBL20379977 | 0.90 | ALDH1A1 (0.48) | TSHRALDH1A1MEN1KMT2AFGFR4 | |
| 2-Ethoxyethanol SCHEMBL29191427 | 0.85 | ALDH1A1 (0.58) | TSHRALDH1A1MEN1KMT2AFGFR4 | |
| Acrylamide SCHEMBL27956962 | 0.85 | TSHR (0.46) | TSHRALDH1A1MEN1KMT2AFGFR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3123542-B1 | GEL ELECTROLYTES AND ELECTRODES | BASF SE (DE) | 2018-01-10 | — | — | EP | disclosed |
| US-9755268-B2 | Gel electrolytes and electrodes | SION POWER CORPORATION (US) | 2017-09-05 | — | — | US | disclosed |
| EP-3123542-A1 | GEL ELECTROLYTES AND ELECTRODES | BASF SE (DE) | 2017-02-01 | — | — | EP | disclosed |
| US-20150280277-A1 | GEL ELECTROLYTES AND ELECTRODES | SION POWER CORPORATION (US) | 2015-10-01 | — | — | US | disclosed |
| US-7683041-B2 | Microgel particles for the delivery of bioactive materials | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-03-23 | — | — | US | disclosed |
| US-20060223776-A1 | Microgel particles for the delivery of bioactive materials | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-10-05 | — | — | US | disclosed |
| US-7056901-B2 | Microgel particles for the delivery of bioactive materials | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-06-06 | — | — | US | disclosed |
| EP-1490083-A1 | MICROGEL PARTICLES FOR THE DELIVERY OF BIOACTIVE MATERIALS | The Regents of the University of California (US) | 2004-12-29 | — | — | EP | disclosed |
| US-20030211158-A1 | Microgel particles for the delivery of bioactive materials | UNITED STATES DEPARTMENT OF ENERGY | 2003-11-13 | — | — | US | disclosed |
| WO-2003082316-A1 | MICROGEL PARTICLES FOR THE DELIVERY OF BIOACTIVE MATERIALS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030211158-A1 | Microgel particles for the delivery of bioactive materials | CTSE, CHMP4B, GAA | TSHR 4770/4885ALDH1A1 2991/4885MEN1 553/4885 |
| US-20060223776-A1 | Microgel particles for the delivery of bioactive materials | CTSE, CHMP4B, GAA | TSHR 4770/4885ALDH1A1 2991/4885MEN1 553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.